Starch Softgel Capsules Market Forecast and Growth 2031

Starch Softgel Capsules Market Size and Forecast (2021 - 2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Application (Pharmaceutical, Health Supplements, and Others), Distribution Channel (Supermarket and Hypermarket, Pharmacy and Drugstore, and Online Providers), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)

  • Report Code : TIPRE00011965
  • Category : Pharmaceuticals
  • No. of Pages : 150
Buy Now

Starch Soft gel Capsules Market | 2031 Strategic Insights

Buy Now

The starch softgel capsules market size in 2021 stood at US$ 414.47 million and is projected to reach US$ 667.29million by 2031 from US$ XX million in 2023. The market is expected to register a CAGR of 5.1% in 2023–2031. Technological innovations in capsule production are likely to remain key starch softgel capsules market trends. Advances in technology are introducing features such as controlled release and tamper-evident properties, making them a flexible choice for pharmaceuticals. In addition, the rise of plant-based capsules is helpful to vegetarians and promotes sustainability.

Starch Softgel Capsules Market Analysis

With increasing consumers adopting plant-based lifestyles and increasing awareness of environmental sustainability, starch softgel capsules present an attractive solution in pharmaceutical and nutraceutical applications. These capsules cater to the demand for plant-derived and eco-friendly healthcare choices. The rapid development of the e-commerce industry and increased government expenditure on healthcare are some factors responsible for the market growth. Growth in the vegan population and high growth potential in emerging markets are anticipated to augment the market's expansion during the forecast period.

Starch Softgel Capsules Market Overview

The starch soft gel capsules are commonly derived from natural sources and are used as nutritional supplements for patients suffering from numerous medical conditions. Soft gel capsules are generally free of genetic modifications and are manufactured adhering to stringent quality standards. The soft gel capsules are also available in gelatin and non-gelatin compositions for those with vegetarian and non-vegetarian preferences. As a plant-based and vegetarian substitute for traditional gelatin capsules, starch softgel capsules have grown in popularity in the pharmaceutical sector. Pharmaceutical companies and customers recognize the advantages of starch softgel capsules in terms of drug delivery and general health and wellbeing, which is surging the demand for these capsules in the market.

Customize Research To Suit Your Requirement

We can optimize and tailor the analysis and scope which is unmet through our standard offerings. This flexibility will help you gain the exact information needed for your business planning and decision making.

Starch Softgel Capsules Market: Strategic Insights

Starch Softgel Capsules Market

  • CAGR (2023 - 2031)
    5.1%
  • Market Size 2021
    US$ 414.47 Million
  • Market Size 2031
    US$ 667.29 Million

Market Dynamics

GROWTH DRIVERS
  • Growing Availability of Vegetarian Softgel Capsules
FUTURE TRENDS
  • Technological Innovations in Capsule Production
OPPORTUNITIES
  • Growing Healthcare Industry Worldwide

Key Players

  • Catalent Inc.
  • Robinson Pharma, Inc.
  • Hunan Er-Kang Pharmaceutical Co., Ltd.
  • Procaps Group
  • CAPTEK Softgel International Inc.
  • Softcaps
  • Fuji Capsule Co., Ltd.
  • Aenova Holding GmbH
  • Sirio Pharma Co., Ltd.
  • Best Formulations, Inc.

Regional Overview

  • North America
  • Europe
  • Asia-Pacific
  • South and Central America
  • Middle East and Africa

Market Segmentation

Application
  • Pharmaceutical
  • Health Supplements
  • Others
Distribution Channel
  • Supermarket and Hypermarket
  • Pharmacy and Drugstore
  • Online Providers
  • Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.

Starch Softgel Capsules Market Drivers and Opportunities

Growing Availability of Vegetarian Softgel Capsules Drives the Market Growth

The general health industry consumer is commencing toward a clear increase in the demand for natural products and pioneering formulations of dosage. Vegetarian softgels have a considerable benefit, as they do not contain any gelatin material derived from animal waste. Most pharmaceutical companies are procuring vegetarian capsules over animal-derived capsules as they have low moisture content and better stability for hygroscopic compounds. These capsules are a perfect and viable alternative for people willing to consume non-gelatin capsules.

These starch softgels fulfill the demand of vegetarians as the capsules can be consumed without the fear of any animal infection or disease. AGS patients experienced severe allergic reactions after taking medications or supplements that include mammalian-derived ingredients. Such instances have prompted manufacturers to develop animal-free medications and supplements. In addition, vegetarian capsules offer the advantages of gelatin capsules with a few additional benefits. The additional advantages make these capsules superior to their traditional counterparts, thereby driving the growth of the market during the forecast period.

Growing Healthcare Industry Worldwide to Favor Market Growth

The healthcare industry has been experiencing rapid transformations over the past few years. Countries worldwide have preferred advanced solutions that are simple and effective in the healthcare industry. With a need for better healthcare facilities, technology-enabled care solutions are being preferred in the healthcare systems in emerging economies. Globally, the size of the healthcare sector is US$10 trillion. The increase in aging population, awareness toward health and fitness, incidences of chronic diseases, and patient compliance toward more acceptable drug delivery formulations are likely to offer growth opportunities to the medical and health nutrition sector. Moreover, India's healthcare sector is growing tremendously due to its strengthening coverage and services and increasing expenditure by public and private players. With groundbreaking investments and visionary policies, the country confirms its commitment to ensuring health and wellness for all citizens. As per a panel discussion estimates on ‘Investments, Healthcare Financing & Private Equity Funding that will shape the future of healthcare’ in 2024, the Indian healthcare sector accounts for US$372 billion. Thus, the increasing emphasis on the advancement of healthcare is expected to complement and offer growth opportunities for the starch softgel capsules market during the forecast period.

Starch Softgel Capsules Market Report Segmentation Analysis

Key segments that contributed to the derivation of the starch softgel capsules market analysis are application and distribution channel.

  • By application, the market is segmented into pharmaceutical, health supplements, others. The health supplements segment held the largest share of the market in 2023 and is projected to register the highest CAGR during the forecast period.
  • Based on distribution channel, the starch softgel capsules market is divided into supermarket and hypermarket, pharmacy and drugstore, and online provider. The pharmacy and drugstore segment held the largest market share in 2023. In addition, the online provider segment is anticipated to register the highest CAGR during the forecast period.

Starch Softgel Capsules Market Share Analysis by Geography

The geographic scope of the starch softgel capsules market report is mainly divided into five regions: North America, Asia Pacific, Europe, Middle East & Africa, and South & Central America.

North America has dominated the starch softgel capsules market. North America market is expanding due to a number of factors, including the increasing availability of softgel capsules as vegetarian options and rising preference for softgel capsules by pharmaceutical and nutraceutical companies. The market for starch softgel capsules in North America is anticipated to increase significantly because chronic diseases are becoming more common, and the need for health supplements to help manage these conditions is propelling market expansion. The existence of numerous manufacturers producing starch-based softgel capsules is another factor fueling the nation's market growth. For example, Grain Processing Corporation sells modified starches called PURE-COTE, which can be combined with other film-forming polymers to create softgel capsules that don't contain gelatin. Additionally, the market for plant-based products among health-conscious customers is expanding, which is fueling the need for starch softgel capsules in the nutraceutical industry. Asia Pacific is anticipated to grow with the highest CAGR in the coming years. The advantages of softgel capsules, rise in preference for vegetarian capsules in Asian countries, and developing healthcare industry are expected to boost the market growth during the forecast period.

Starch Softgel Capsules Market Report Scope

Report Attribute Details
Market size in 2021 US$ 414.47 Million
Market Size by 2031 US$ 667.29 Million
Global CAGR (2023 - 2031) 5.1%
Historical Data 2021-2022
Forecast period 2024-2031
Segments Covered By Application
  • Pharmaceutical
  • Health Supplements
  • Others
By Distribution Channel
  • Supermarket and Hypermarket
  • Pharmacy and Drugstore
  • Online Providers
Regions and Countries Covered North America
  • US
  • Canada
  • Mexico
Europe
  • UK
  • Germany
  • France
  • Russia
  • Italy
  • Rest of Europe
Asia-Pacific
  • China
  • India
  • Japan
  • Australia
  • Rest of Asia-Pacific
South and Central America
  • Brazil
  • Argentina
  • Rest of South and Central America
Middle East and Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Rest of Middle East and Africa
Market leaders and key company profiles
  • Catalent Inc.
  • Robinson Pharma, Inc.
  • Hunan Er-Kang Pharmaceutical Co., Ltd.
  • Procaps Group
  • CAPTEK Softgel International Inc.
  • Softcaps
  • Fuji Capsule Co., Ltd.
  • Aenova Holding GmbH
  • Sirio Pharma Co., Ltd.
  • Best Formulations, Inc.
    • Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.

    Starch Softgel Capsules Market News and Recent Developments

    The starch softgel capsules market is evaluated by gathering qualitative and quantitative data post primary and secondary research, which includes important corporate publications, association data, and databases. The following is a list of developments in the market for starch softgel capsules and strategies:

    • Roquette, a global leader in plant-based ingredients and a leading provider of nutraceutical and pharmaceutical excipients, showcased a new flexible addition to its LYCAGEL hydroxypropyl pea starch excipient range at Vitafoods Europe 2024, along with a fresh vision for developing vegetarian and vegan dietary supplements in softgels. (Source: Roquette Pharma Solutions, Press Release, 2024)
    • ACG, a leading supplier of fully integrated solutions to the global pharmaceutical and nutraceutical industry, introduced its new ACGcaps NTone and ACGcaps TSafe range of capsules for the Nutraceutical market. ACGcaps NTone is a portfolio of naturally colored capsules with no e-number. This new range creates the perfect opportunity for formulating clean-label products. (Source: ACG, Press Release, 2021)

    Starch Softgel Capsules Market Report Coverage and Deliverables

    The “Starch Softgel Capsules Market Size and Forecast (2021–2031)” report provides a detailed analysis of the market covering below areas:

    • Market size and forecast at global, regional, and country levels for all the key market segments covered under the scope.
    • Market dynamics such as drivers, restraints, and key opportunities
    • Key future trends
    • Detailed PEST/Porter’s Five Forces and SWOT analysis
    • Global and regional market analysis covering key market trends, major players, regulations, and recent market developments
    • Industry landscape and competition analysis covering market concentration, heat map analysis, prominent players, and recent developments
    • Detailed company profiles
    Report Coverage
    Report Coverage

    Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

    Segment Covered
    Segment Covered

    Application ; Distribution Channel , and Geography

    Regional Scope
    Regional Scope

    North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

    Country Scope
    Country Scope

    Argentina, Australia, Brazil, Canada, China, France, Germany, India, Italy, Japan, Mexico, Saudi Arabia, South Africa, South Korea, Spain, United Arab Emirates, United Kingdom, United States

    Trends and growth analysis reports related to Pharmaceuticals : READ MORE..